You have 9 free searches left this month | for more free features.

Metastatic Breast Cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Trastuzumab deruxtecan
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Aug 7, 2023

Discovering Factors in Metastatic Breast Cancer Patients'

Not yet recruiting
  • Metastatic Breast Cancer
    • (no location specified)
    Feb 25, 2023

    Metastatic Breast Cancer Trial in Philadelphia (Adapted Intimacy Enhancement, Intimacy Facts and Resources)

    Recruiting
    • Metastatic Breast Cancer
    • Adapted Intimacy Enhancement
    • Intimacy Facts and Resources
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Dec 5, 2022

    Metastatic Breast Cancer-Specific Prognostic Tool

    Recruiting
    • Metastatic Breast Cancer
    • Patients and Caregivers Qualitative Interview
    • Chapel Hill, North Carolina
      Terri Eubanks
    Oct 7, 2022

    Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

    Recruiting
    • Breast Cancer
    • +2 more
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 8, 2023

      Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

      Not yet recruiting
      • Metastatic Breast Cancer
        • Kingston, Ontario, Canada
        • +1 more
        Mar 27, 2023

        Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

        Not yet recruiting
        • Metastatic Breast Cancer
        • Lobular Breast Carcinoma
        • Blood Specimen
        • San Francisco, California
          University of California, San Francisco
        Jul 19, 2023

        Germline and Somatic Pathogenic Variants in de Novo Metastatic

        Active, not recruiting
        • Metastatic Breast Cancer
        • NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
        • Athens, Greece
          Evangelia Moirogiorgou
        Mar 7, 2023

        Metastatic Breast Cancer Trial in Milwaukee (Lifestyle Intervention)

        Recruiting
        • Metastatic Breast Cancer
        • Lifestyle Intervention
        • Attention Control
        • Milwaukee, Wisconsin
          Medical College of Wisconsin
        Dec 16, 2022

        Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

        Not yet recruiting
        • Metastatic Breast Cancer
        • (no location specified)
        Jul 12, 2023

        Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)

        Not yet recruiting
        • Breast Cancer
        • +3 more
        • Lipidomic analysis for breast cancer patients
        • Roma, Italy
          Fondazione Policlinico Universitario A. Gemelli IRCCS
        Sep 4, 2023

        Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Metastatic Breast Cancer
        • Sacituzumab govitecan
        • (no location specified)
        Jan 23, 2023

        Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

        Recruiting
        • Metastatic Breast Cancer
        • Taipei City, Please Select, Taiwan
        • +2 more
        Nov 27, 2022

        Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

        Recruiting
        • Breast Cancer
        • +2 more
        • Madison, Wisconsin
          University of Wisconsin School of Medicine and Public Health
        Oct 18, 2022

        Metastatic Breast Cancer Trial (Elacestrant)

        Not yet recruiting
        • Metastatic Breast Cancer
        • (no location specified)
        Oct 24, 2022

        Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Brain Metastases
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Nov 17, 2022

        HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

        Not yet recruiting
        • HER2-PositiveRecurrent or Metastatic Breast Cancer
        • SHR-A1811 Injection
        • +2 more
        • (no location specified)
        Sep 21, 2023

        HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)

        Not yet recruiting
        • HER2-positive Recurrent/Metastatic Breast Cancer
        • Inetetamab, pyrotinib, chemotherapy
        • (no location specified)
        Nov 16, 2022

        Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)

        Recruiting
        • Metastatic Breast Cancer
        • +2 more
        • Haifa, Israel
          Rambam Health Care Campus
        Feb 22, 2023

        DESTINY Breast Respond HER2-low Europe

        Not yet recruiting
        • Unresectable Breast Cancer
        • +2 more
        • Trastuzumab deruxtecan
        • (no location specified)
        Jul 6, 2023

        Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

        Not yet recruiting
        • Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
        • identify biomarkers
        • (no location specified)
        May 13, 2023

        Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

        Recruiting
        • Breast Cancer
        • metronomic oral vinorelbine plus anlotinib
        • Xi'an, Shaanxi, China
          Xi'an International Medical Center Hospital
        Aug 27, 2023

        Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)

        Recruiting
        • Metastatic Breast Cancer
        • HER2 BATs with Pembrolizumab
        • Charlottesville, Virginia
          Ashley Donihee
        Jan 18, 2023

        Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

        Not yet recruiting
        • Advanced or Metastatic Breast Cancer
        • Milademetan
        • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
        • Paris, France
          Institut Curie
        Jun 27, 2023